Pancreatic Cancer Research

ResearcherChina Pharmaceutical UniversityActive in the last 2 years

Ying Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2571-9367; OpenAlex author ID A5114994797. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. The function of microRNA related to cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.bcp.2025.116849↗
  2. Histone methylation in pancreatic cancer and its clinical implications. Last author DOI 10.3748/wjg.v27.i36.6004↗
  3. Experimental study on the therapeutic effect and underlining mechanisms of positron in pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.18366↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhenjiang Zheng · 1 shared paper, 2025 · strength 0.20
  2. Jia Chen · 1 shared paper, 2025 · strength 0.20
  3. Chunlu Tan · 1 shared paper, 2025 · strength 0.20
  4. Epiphane K. Silli · 1 shared paper, 2025 · strength 0.20
  5. Yaohui Fang · 1 shared paper, 2025 · strength 0.20
  6. Lisha Li · 1 shared paper, 2021 · strength 0.15
  7. Xingyu Liu · 1 shared paper, 2021 · strength 0.15
  8. Yaming Li · 1 shared paper, 2017 · strength 0.08
  9. Ming Li · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.